United States
The United States is a leading market for multiplex assays due to its robust healthcare system and high investment in research and development. The demand for multiplex assays is fueled by the increasing need for precise diagnostic tools for diseases like cancer, autoimmune disorders, and infectious diseases. The growing focus on early diagnosis, along with public awareness and...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian